James R. Mcnab - Jan 28, 2022 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
Director
Signature
/S/ James R. McNab
Stock symbol
TTNP
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
4
Date filed
1/28/2022, 02:14 PM
Previous filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock Other +51K 51K Jan 28, 2022 By JT Pharma F1
holding TTNP Common Stock 1.67K Jan 28, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents $50,000 of shares issued to JT Pharmaceuticals, Inc. ("JT") as a milestone payment under the October 2020 asset purchase agreement. Mr. McNab is a principal of JT and has voting and dispositive control of such shares.